Reid Hastie
Tracked across 5 events · 32 articles · First seen May 27, 2026 · Last active Sep 08, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: As CEO of Metabolon, Reid Hastie announced the Metabolon Verus Metabolomics Profiling Kit, highlighting its potential to address standardization and reproducibility challenges in metabolomics.
May 27, 2026 · 8 articles
Tech
Impact: As CEO, Reid Hastie commented on the panel expansion, emphasizing its potential to uncover molecular mechanisms linking microbial activity to host health.
Jul 15, 2026 · 6 articles
Tech
Metabolon announced on September 8, 2026 that its Metabolon Verus Metabolomics Profiling Kit is now available to order in North American markets, marking the company's first decentralized product and its transition from early access to…
Impact: Reid Hastie, CEO of Metabolon, announced the commercial availability, framing it as a key milestone. His leadership is central to the company's strategic move into decentralized products.
Jul 20, 2026 · 6 articles
Business
Impact: Reid Hastie, as CEO, is the public spokesperson for the program, reinforcing his leadership and the company's strategic direction.
Aug 11, 2026 · 6 articles
Tech
Impact: Reid Hastie, CEO of Metabolon, commented on the company's ability to support global health research, reinforcing Metabolon's strategic positioning.
Jul 20, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Reid Hastie live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard